Literature DB >> 23664085

Irisin: a renaissance in metabolism?

Stergios A Polyzos, Jannis Kountouras, Kelsey Shields, Christos S Mantzoros.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23664085     DOI： 10.1016/j.metabol.2013.04.008

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  44 in total

1.  Circulating irisin, omentin-1, and lipoprotein subparticles in adults at higher cardiovascular risk.

Authors:  Grigorios Panagiotou; Lin Mu; Brian Na; Kenneth J Mukamal; Christos S Mantzoros
Journal:  Metabolism       Date:  2014-06-09       Impact factor: 8.694

2.  Association between circulating irisin and homocysteine in patients with nonalcoholic fatty liver disease.

Authors:  Stergios A Polyzos; Jannis Kountouras; Athanasios D Anastasilakis; Anastasia Margouta; Christos S Mantzoros
Journal:  Endocrine       Date:  2014-11-09       Impact factor: 3.633

3.  Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury.

Authors:  Hao Wang; Yu Tina Zhao; Shouyan Zhang; Patrycja M Dubielecka; Jianfeng Du; Naohiro Yano; Y Eugene Chin; Shougang Zhuang; Gangjian Qin; Ting C Zhao
Journal:  J Cell Physiol       Date:  2017-05-03       Impact factor: 6.384

Review 4.  Irisin in metabolic diseases.

Authors:  Stergios A Polyzos; Athanasios D Anastasilakis; Zoe A Efstathiadou; Polyzois Makras; Nikolaos Perakakis; Jannis Kountouras; Christos S Mantzoros
Journal:  Endocrine       Date:  2017-11-23       Impact factor: 3.633

5.  Irisin, a unique non-inflammatory myokine in stimulating skeletal muscle metabolism.

Authors:  Roger A Vaughan; Nicholas P Gannon; Christine M Mermier; Carole A Conn
Journal:  J Physiol Biochem       Date:  2015-09-23       Impact factor: 4.158

Review 6.  Chronic Exercise Training and Circulating Irisin in Adults: A Meta-Analysis.

Authors:  Shanhu Qiu; Xue Cai; Zilin Sun; Uwe Schumann; Martina Zügel; Jürgen Michael Steinacker
Journal:  Sports Med       Date:  2015-11       Impact factor: 11.136

7.  Circulating irisin in relation to insulin resistance and the metabolic syndrome.

Authors:  Kyung Hee Park; Lesya Zaichenko; Mary Brinkoetter; Bindiya Thakkar; Ayse Sahin-Efe; Kyoung Eun Joung; Michael A Tsoukas; Eleni V Geladari; Joo Young Huh; Fadime Dincer; Cynthia R Davis; Judith A Crowell; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2013-09-20       Impact factor: 5.958

8.  Decreased Concentration of Irisin Is Associated with Poor Functional Outcome in Ischemic Stroke.

Authors:  Wen-Jun Tu; Han-Cheng Qiu; Jian-Lei Cao; Qiang Liu; Xian-Wei Zeng; Ji-Zong Zhao
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

9.  Activin A and follistatin in patients with nonalcoholic fatty liver disease.

Authors:  Stergios A Polyzos; Jannis Kountouras; Athanasios D Anastasilakis; Georgios Α Triantafyllou; Christos S Mantzoros
Journal:  Metabolism       Date:  2016-07-25       Impact factor: 8.694

10.  Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies.

Authors:  Timea Kurdiova; Miroslav Balaz; Marek Vician; Denisa Maderova; Miroslav Vlcek; Ladislav Valkovic; Miroslav Srbecky; Richard Imrich; Olga Kyselovicova; Vitazoslav Belan; Ivan Jelok; Christian Wolfrum; Iwar Klimes; Martin Krssak; Erika Zemkova; Daniela Gasperikova; Jozef Ukropec; Barbara Ukropcova
Journal:  J Physiol       Date:  2013-12-02       Impact factor: 5.182
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.